Speaker illustration

Doctor Julian Gillmore

UCL, Greater London (United Kingdom of Great Britain & Northern Ireland)

Julian Gillmore gained his medical degree at University of London and was appointed Professor of Medicine at University College London in 2017. He trained in nephrology and undertook MD and PhD degrees in the field of amyloidosis. His research interests include pathogenesis, diagnosis and treatment of amyloidosis. He was appointed Centre Head at UCL’s Centre for Amyloidosis & Acute Phase Proteins in 2019 and is clinical lead for ATTR amyloidosis at the UK National Amyloidosis Centre. He has published more than 250 peer-reviewed articles, has supervised a number of students through their post-doctoral research degrees, and has received extensive grant funding.

Long-term integrated safety of patisiran in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Infiltrative Myocardial Disease

Session: Myocardial Disease ePosters


This platform is supported by

logo Novo Nordisk